Clinuvel Pharmaceuticals
CUV.AX
#6929
Rank
ยฃ0.34 B
Marketcap
ยฃ6.81
Share price
-1.79%
Change (1 day)
-20.14%
Change (1 year)

Revenue for Clinuvel Pharmaceuticals (CUV.AX)

Revenue in 2023: ยฃ41.13 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ41.13 Million. In 2023 the company made a revenue of ยฃ41.13 Million an increase over the revenue in the year 2022 that were of ยฃ35.88 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Clinuvel Pharmaceuticals from 2001 to 2023

Annual revenue

Year Revenue Change
2023ยฃ41.13 M14.65%
2022ยฃ35.88 M25.45%
2021ยฃ28.6 M61.08%
2020ยฃ17.75 M2.65%
2019ยฃ17.29 M15.55%
2018ยฃ14.97 M46.83%
2017ยฃ10.19 M176.95%
2016ยฃ3.68 M107.69%
2015ยฃ1.77 M7.83%
2014ยฃ1.64 M45.96%
2013ยฃ1.12 M91.73%
2012ยฃ0.58 M-33.49%
2011ยฃ0.88 M
2010N/A
2009N/A
2008N/A-100%
2007ยฃ0.19 M-57.21%
2006ยฃ0.44 M489.62%
2005ยฃ0.07 M
2004N/A
2002N/A
2001N/A